Literature DB >> 26104818

Characterization of protocols for primary trophoblast purification, optimized for functional investigation of sFlt-1 and soluble endoglin.

Tu'uhevaha J Kaitu'u-Lino1, Stephen Tong2, Sally Beard2, Roxanne Hastie2, Laura Tuohey2, Fiona Brownfoot2, Kenji Onda2, Natalie J Hannan2.   

Abstract

OBJECTIVES: Soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng) are the most studied molecules in preeclampsia. However, most trophoblast cell lines do not secrete both these factors. Thus, we set out to characterize protocols to functionally investigate sFlt-1 and sEng from primary trophoblast. STUDY
DESIGN: Primary trophoblasts were isolated from term placenta by percoll gradient, then negative selection using a CD9 antibody. Purity was assessed by cytokeratin 7 immunostaining. We first examined the effects of CD9 negative selection on sFlt-1, sEng and hCG secretion and the ability of forskolin to enhance syncytialization. We then examined the effects of hypoxia on sFlt-1 production and assessed gene knockdown using siRNA.
RESULTS: CD9 negative selection produced a pure population of primary trophoblasts. Secretion of sEng was 5-fold lower when CD9-positive cells were removed, sFlt1 was unchanged, and hCG was significantly increased. hCG analysis of the purified population indicated spontaneous syncytialization, which was not enhanced by forskolin. Forskolin similarly did not alter sFlt-1 secretion. Hypoxia significantly increased sFlt-1 secretion as expected. Importantly, high gene silencing efficiencies were readily achieved.
CONCLUSION: In conclusion, we present a protocol that yields primary trophoblasts of high purity that produce abundant sFlt-1 and low but detectable levels of sEng. Furthermore, these cells are readily amenable to gene silencing by siRNAs and hence suitable for functional studies.
Copyright © 2014 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Placenta; Soluble endoglin; Trophoblast; sFlt-1

Year:  2014        PMID: 26104818     DOI: 10.1016/j.preghy.2014.09.003

Source DB:  PubMed          Journal:  Pregnancy Hypertens        ISSN: 2210-7789            Impact factor:   2.899


  14 in total

1.  Characterization of 5-methylcytosine and 5-hydroxymethylcytosine in human placenta cell types across gestation.

Authors:  Rebecca L Wilson; Maxime François; Tanja Jankovic-Karasoulos; Dale McAninch; Dylan McCullough; Wayne R Leifert; Claire T Roberts; Tina Bianco-Miotto
Journal:  Epigenetics       Date:  2019-04-30       Impact factor: 4.528

2.  Isolation of villous cytotrophoblasts from second trimester human placentas.

Authors:  Tanja Jankovic-Karasoulos; Dale McAninch; Dylan McCullough; Rebecca L Wilson; Tina Bianco-Miotto; Claire T Roberts
Journal:  Placenta       Date:  2018-11-22       Impact factor: 3.481

3.  Causative Effects of Genetically Determined High Maternal/Fetal Endothelin-1 on Preeclampsia-Like Conditions in Mice.

Authors:  Feng Li; Masao Kakoki; Marcela Smid; Kim Boggess; Jennifer Wilder; Sylvia Hiller; Carol Bounajim; Scott E Parnell; Kathleen K Sulik; Oliver Smithies; Nobuyo Maeda-Smithies
Journal:  Hypertension       Date:  2018-04-02       Impact factor: 10.190

4.  Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.

Authors:  Natalie J Hannan; Fiona C Brownfoot; Ping Cannon; Minh Deo; Sally Beard; Tuong V Nguyen; Kirsten R Palmer; Stephen Tong; Tu'uhevaha J Kaitu'u-Lino
Journal:  Sci Rep       Date:  2017-05-12       Impact factor: 4.379

5.  Combining metformin and esomeprazole is additive in reducing sFlt-1 secretion and decreasing endothelial dysfunction - implications for treating preeclampsia.

Authors:  Tu'uhevaha J Kaitu'u-Lino; Fiona C Brownfoot; Sally Beard; Ping Cannon; Roxanne Hastie; Tuong V Nguyen; Natalie K Binder; Stephen Tong; Natalie J Hannan
Journal:  PLoS One       Date:  2018-02-21       Impact factor: 3.240

6.  Circulating GATA2 mRNA is decreased among women destined to develop preeclampsia and may be of endothelial origin.

Authors:  Carole-Anne Whigham; Teresa M MacDonald; Susan P Walker; Natasha Pritchard; Natalie J Hannan; Ping Cannon; Tuong Vi Nguyen; Roxanne Hastie; Stephen Tong; Tu'uhevaha J Kaitu'u-Lino
Journal:  Sci Rep       Date:  2019-01-18       Impact factor: 4.379

7.  HtrA4 is up-regulated during trophoblast syncytialization and BeWo cells fail to syncytialize without HtrA4.

Authors:  Mary Mansilla; Yao Wang; Rebecca Lim; Kirsten Palmer; Guiying Nie
Journal:  Sci Rep       Date:  2021-07-13       Impact factor: 4.379

8.  Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.

Authors:  Fiona C Brownfoot; Stephen Tong; Natalie J Hannan; Roxanne Hastie; Ping Cannon; Tu'uhevaha J Kaitu'u-Lino
Journal:  BMC Pregnancy Childbirth       Date:  2016-05-20       Impact factor: 3.007

9.  Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.

Authors:  Natalie J Hannan; Natalie K Binder; Sally Beard; Tuong-Vi Nguyen; Tu'uhevaha J Kaitu'u-Lino; Stephen Tong
Journal:  PLoS One       Date:  2018-04-11       Impact factor: 3.240

10.  MicroRNAs 363 and 149 are differentially expressed in the maternal circulation preceding a diagnosis of preeclampsia.

Authors:  Carole-Anne Whigham; Teresa M MacDonald; Susan P Walker; Richard Hiscock; Natalie J Hannan; Natasha Pritchard; Ping Cannon; Tuong Vi Nguyen; Manisha Miranda; Stephen Tong; Tu'uhevaha J Kaitu'u-Lino
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.